SMARCE1 and meningioma: We first examined how meningiomas of Grades 1, 2 and 3 and ungraded meningiomas allocate to the predicted MCs meningioma benign, intermediate, malignant and the MC meningioma, SMARCE1‐altered, and how these meningiomas resolve into the model scores of 0–9.